Back to search results

The MOMI Study for Postpartum Health

This study, called The Mom and Infant Outcomes (MOMI) Study, is looking at ways to improve the health of mothers and infants after pregnancy. It's for women who are pregnant and have a current or past diagnosis of certain conditions like high blood pressure or preeclampsia. The study compares two approaches: MOMI PODS, which is a new way of providing primary care after birth, and Enhanced Usual Care, which is an improved version of standard care. Researchers want to see if MOMI PODS can help reduce risks related to pregnancy, such as postpartum depression, anxiety, and heart-related issues. Success in this study would mean participants have better overall health scores, fewer symptoms of depression and anxiety, and fewer emergency visits or hospital readmissions. The study plans to enroll up to 384 mother-infant pairs, but its current recruitment status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It is a randomized controlled trial, comparing MOMI PODS to Enhanced Usual Care, with up to 384 mother-infant pairs.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants' health will be monitored from the start of the study (baseline) up to 12 months postpartum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06277661

The Mom and Infant Outcomes (MOMI) Study

Recruiting
NAAll AgesInterventionalPrevention
Ohio State University
~384 participants
Updated 2026-05-14 on ClinicalTrials.gov
What's tested:MOMI PODSEnhanced Usual Care (EUC)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Life's Essential 8 (LE8) Composite Score
Measured over Baseline (T1) to 6 months postpartum (T2)
+8 more outcomes measured

Conditions

Postpartum Depression
Postpartum Anxiety
Cardiometabolic Syndrome

Explore related trials

Anxiety DisorderDepressive disorderDiabetes MellitusEclampsiaHELLP SyndromeHypertensionPreeclampsia

Where it's being run

1 sites across 1 states
Ohio1

Who to contact

Shannon L. Gillespie, PhD, RN
[email protected]
6142924589
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Change in Life's Essential 8 (LE8) Composite ScoreBaseline (T1) to 6 months postpartum (T2)

    Higher scores=better health (0-100). 0-100 points for each domain. Total divided by 8. Diet (Mediterranean Eating Pattern for Americans score): 100=15-16; 80=12-14; 50=8-11; 25=4-7; 0=0-3; Physical Activity (min. moderate+/week): 100=\>=150; 90=120-149; 80=90-119; 60=60-89; 40=30-59; 20=1-29; 0=0; Nicotine: 100=Never; 75=Former, quit \>=5y; 50=Former, quit 1-\<5y; 25=Former, quit \<1y or vaping; 0=Current; -20 living with indoor smoker; Sleep (avg. hrs./night): 100=7\<9; 90=9-\<10; 70=6-\<7; 40=5-\<6 or \>=10; 20=4-\<5; 0=\<4; body mass index (kg/m2): 100=\<25; 70=25-29.9; 30=30-34.9; 15=35-39.9; 0=\>=40; Non-HDL mg/dL: 100=\<130; 60=130-159; 40=160-189; 20=190-219; 0=\>=220; -20 if treated; Glucose (Diabetes/HbA1c): 100=No/\<5.7; 60=No/5.7-6.4; 40=Yes/\<7; 30=Yes/7-7.9; 20=Yes/8-8.9; 10=Yes/9-9.9; 0=Yes/\>=10; Blood pressure: 100=\<120/\<80; 75=120-129/\<80; 50=130-139 or 80-89; 25=140-159 or 90-99; 0=\>=160 or \>=100; -20 if treated

  • Change in Life's Essential 8 (LE8) Composite Score6 months postpartum (T2) to 12 months postpartum (T3)

    Higher scores=better health (0-100). 0-100 points for each domain. Total divided by 8. Diet (Mediterranean Eating Pattern for Americans score): 100=15-16; 80=12-14; 50=8-11; 25=4-7; 0=0-3; Physical Activity (min. moderate+/week): 100=\>=150; 90=120-149; 80=90-119; 60=60-89; 40=30-59; 20=1-29; 0=0; Nicotine: 100=Never; 75=Former, quit \>=5y; 50=Former, quit 1-\<5y; 25=Former, quit \<1y or vaping; 0=Current; -20 living with indoor smoker; Sleep (avg. hrs./night): 100=7\<9; 90=9-\<10; 70=6-\<7; 40=5-\<6 or \>=10; 20=4-\<5; 0=\<4; body mass index (kg/m2): 100=\<25; 70=25-29.9; 30=30-34.9; 15=35-39.9; 0=\>=40; Non-HDL mg/dL: 100=\<130; 60=130-159; 40=160-189; 20=190-219; 0=\>=220; -20 if treated; Glucose (Diabetes/HbA1c): 100=No/\<5.7; 60=No/5.7-6.4; 40=Yes/\<7; 30=Yes/7-7.9; 20=Yes/8-8.9; 10=Yes/9-9.9; 0=Yes/\>=10; Blood pressure: 100=\<120/\<80; 75=120-129/\<80; 50=130-139 or 80-89; 25=140-159 or 90-99; 0=\>=160 or \>=100; -20 if treated

  • Change in Life's Essential 8 (LE8) Composite ScoreBaseline (T1) to 12 months postpartum (T3)

    Higher scores=better health (0-100). 0-100 points for each domain. Total divided by 8. Diet (Mediterranean Eating Pattern for Americans score): 100=15-16; 80=12-14; 50=8-11; 25=4-7; 0=0-3; Physical Activity (min. moderate+/week): 100=\>=150; 90=120-149; 80=90-119; 60=60-89; 40=30-59; 20=1-29; 0=0; Nicotine: 100=Never; 75=Former, quit \>=5y; 50=Former, quit 1-\<5y; 25=Former, quit \<1y or vaping; 0=Current; -20 living with indoor smoker; Sleep (avg. hrs./night): 100=7\<9; 90=9-\<10; 70=6-\<7; 40=5-\<6 or \>=10; 20=4-\<5; 0=\<4; body mass index (kg/m2): 100=\<25; 70=25-29.9; 30=30-34.9; 15=35-39.9; 0=\>=40; Non-HDL mg/dL: 100=\<130; 60=130-159; 40=160-189; 20=190-219; 0=\>=220; -20 if treated; Glucose (Diabetes/HbA1c): 100=No/\<5.7; 60=No/5.7-6.4; 40=Yes/\<7; 30=Yes/7-7.9; 20=Yes/8-8.9; 10=Yes/9-9.9; 0=Yes/\>=10; Blood pressure: 100=\<120/\<80; 75=120-129/\<80; 50=130-139 or 80-89; 25=140-159 or 90-99; 0=\>=160 or \>=100; -20 if treated

  • Change in Patient Health Questionnaire-9 (PHQ-9) ScoreBaseline (T1) to 6 months postpartum (T2)

    We will assess mental health by self-report using the Patient Health Questionnaire-9 (PHQ-9), with higher scores indicative of more depressive symptoms (range 0-27).

  • Change in Patient Health Questionnaire-9 (PHQ-9) Score6 months postpartum (T2) to 12 months postpartum (T3)

    We will assess mental health by self-report using the Patient Health Questionnaire-9 (PHQ-9), with higher scores indicative of more depressive symptoms (range 0-27).

  • Change in Patient Health Questionnaire-9 (PHQ-9) ScoreBaseline (T1) to 12 months postpartum (T3)

    We will assess mental health by self-report using the Patient Health Questionnaire-9 (PHQ-9), with higher scores indicative of more depressive symptoms (range 0-27).

  • Change in Generalized Anxiety Disorder-7 (GAD-7) ScoreBaseline (T1) to 6 months postpartum (T2)

    We will assess mental health by self-report using the Generalized Anxiety Disorder-7 (GAD-7), with higher scores indicative of more anxiety symptoms (range 0-21).

  • Change in Generalized Anxiety Disorder-7 (GAD-7) Score6 months postpartum (T2) to 12 months postpartum (T3)

    We will assess mental health by self-report using the Generalized Anxiety Disorder-7 (GAD-7), with higher scores indicative of more anxiety symptoms (range 0-21).

  • Change in Generalized Anxiety Disorder-7 (GAD-7) ScoreBaseline (T1) to 12 months postpartum (T3)

    We will assess mental health by self-report using the Generalized Anxiety Disorder-7 (GAD-7), with higher scores indicative of more anxiety symptoms (range 0-21).